Open AccessClinical practice guidelines for the diagnosis and treatment of adult diffuse glioma‐related epilepsy
Author(s) -
Liang Shuli,
Fan Xing,
Zhao Ming,
Shan Xia,
Li Wenling,
Ding Ping,
You Gan,
Hong Zhen,
Yang Xuejun,
Luan Guoming,
Ma Wenbin,
Yang Hui,
You Yongpin,
Yang Tianming,
Li Liang,
Liao Weiping,
Wang Lei,
Wu Xun,
Yu Xinguang,
Zhang Jianguo,
Mao Qing,
Wang Yuping,
Li Wenbin,
Wang Xuefeng,
Jiang Chuanlu,
Liu Xiaoyan,
Qi Songtao,
Liu Xingzhou,
Qu Yan,
Xu Jiwen,
Wang Weimin,
Song Zhi,
Wu Jinsong,
Liu Zhixiong,
Chen Ling,
Lin Yuanxiang,
Zhou Jian,
Liu Xianzeng,
Zhang Wei,
Li Shichuo,
Jiang Tao
Publication year - 2019
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.2362
Subject(s) - guideline , psychosocial , medicine , epilepsy , glioma , clinical practice , task force , quality of life (healthcare) , quality assurance , medline , intensive care medicine , medical physics , family medicine , psychiatry , pathology , nursing , external quality assessment , cancer research , public administration , political science , law
Abstract Background Glioma‐related epilepsy (GRE) is defined as symptomatic epileptic seizures secondary to gliomas, it brings both heavy financial and psychosocial burdens to patients with diffuse glioma and significantly decreases their quality of life. To date, there have been no clinical guidelines that provide recommendations for the optimal diagnostic and therapeutic procedures for GRE patients. Methods In March 2017, the Joint Task Force for GRE of China Association Against Epilepsy and Society for Neuro‐Oncology of China launched the guideline committee for the diagnosis and treatment of GRE. The guideline committee conducted a comprehensive review of relevant domestic and international literatures that were evaluated and graded based on the Oxford Centre for Evidence‐Based Medicine Levels of Evidence, and then held three consensus meetings to discuss relevant recommendations. The recommendations were eventually given according to those relevant literatures, together with the experiences in the diagnosis and treatment of over 3000 GRE cases from 24 tertiary level hospitals that specialize in clinical research of epilepsy, glioma, and GRE in China. Results The manuscript presented the current standard recommendations for the diagnostic and therapeutic procedures of GRE. Conclusions The current work will provide a framework and assurance for the diagnosis and treatment strategy of GRE to reduce complications and costs caused by unnecessary treatment. Additionally, it can serve as a reference for all professionals involved in the management of patients with GRE.